focetria: Clinical Trials

3 trials of focetria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Unknown 1

Follow focetria: new trials by email Literature Review of focetria trials Research Report on focetria

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
H1N1sw Vaccine in Adult Transplant Recipients
Focetria (2x H1N1 vaccine with MF59 adjuvants) - Immunocompromised
Phase 2TerminatedHepNet Study House, German Liverfoundation132010-02-012012-04-16
Vaccination Against Influenza H1N1 in Rheumatic Diseases
Focetria (Monovalent MF59-Adjuvanted vaccine) - Influenza, Rheumatic Diseases
Phase 2UnknownTel-Aviv Sourasky Medical Center4002009-11-012009-11-03
A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
MF59 adjuvanted H1N1 influenza monovalent vaccine, Thymosin alpha 1 - END STAGE RENAL DISEASE
Phase 2Completedsigma-tau i.f.r. S.p.A.1202009-11-012012-03-29

Conditions studied

Arthritis, Psoriatic (1)  ·  Influenza, Human (1)  ·  Kidney Failure, Chronic (1)  ·  Rheumatic Diseases (1)

Sponsors

HepNet Study House, German Liverfoundation (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  sigma-tau i.f.r. S.p.A. (1)

Countries

Germany (1)  ·  Italy (1)

Top investigators

Agostino Naso, MD (1)  ·  Michael P Manns, Prof (1)

Results publications

PMID 21425247

NIH funding

2009 (1)